Journal of Pharmaceutical Analysis Template
Write in a clean editor, then format for Journal of Pharmaceutical Analysis in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Journal of Pharmaceutical Analysis format
Journal of Pharmaceutical Analysis is a peer-reviewed journal published by Elsevier, covering Analytical Chemistry and Chromatography, Analytical Methods in Pharmaceuticals, Metabolomics and Mass Spectrometry Studies.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Journal of Pharmaceutical Analysis 12 (2023) 45–58.
Formats any DOI in Journal of Pharmaceutical Analysis style. No sign-up. |
| Publishes research in | Analytical Chemistry and Chromatography Analytical Methods in Pharmaceuticals Metabolomics and Mass Spectrometry Studies Educational Robotics and Engineering Human auditory perception and evaluation |
| ISSN | 2095-1779 |
| Citation impact (2-yr) | 6.09 |
| h-index | 81 |
| i10-index | 877 |
| Total citations | 45,695 |
| Article processing charge | $1,800 |
| Open access | Yes |
| Top institutions publishing here | Chinese Academy of Medical Sciences & Peking Union Medical College |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Journal of Pharmaceutical Analysis per year
Citation impact of Journal of Pharmaceutical Analysis by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of Pharmaceutical Analysis
Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome…
The recent pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has raised global health concerns. The viral 3-chymotrypsin-like cysteine protease (3CLpro) enzyme controls coronavirus replication and is essential for its life cycle. 3CLpro is a proven drug discovery target in the case of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome…
Forced degradation is a degradation of new drug substance and drug product at conditions more severe than accelerated conditions. It is required to demonstrate specificity of stability indicating methods and also provides an insight into degradation pathways and degradation products of the drug substance and helps in elucidation of the structure of the degradation products.…
The recent pneumonia outbreak caused by a novel coronavirus (SARS-CoV-2) is posing a great threat to global public health. Therefore, rapid and accurate identification of pathogenic viruses plays a vital role in selecting appropriate treatments, saving people's lives and preventing epidemics. It is important to establish a quick standard diagnostic test for the detection of…